BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 9865840)

  • 1. Cyclin D1 and MIB-1 immunohistochemistry in pilocytic astrocytomas: a study of 48 cases.
    Machen SK; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1511-6. PubMed ID: 9865840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 and MIB-1 immunohistochemistry in ependymomas: a study of 41 cases.
    Prayson RA
    Am J Clin Pathol; 1998 Nov; 110(5):629-34. PubMed ID: 9802348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proliferative potential of the pilocytic astrocytoma: the relation between MIB-1 labeling and clinical and neuro-radiological follow-up.
    Dirven CM; Koudstaal J; Mooij JJ; Molenaar WM
    J Neurooncol; 1998 Mar; 37(1):9-16. PubMed ID: 9525833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of 61 patients with ependymoma including MIB-1 immunohistochemistry.
    Prayson RA
    Ann Diagn Pathol; 1999 Feb; 3(1):11-8. PubMed ID: 9990108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptotic and proliferative markers in chordomas: a study of 26 tumors.
    Kilgore S; Prayson RA
    Ann Diagn Pathol; 2002 Aug; 6(4):222-8. PubMed ID: 12170453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxopapillary ependymomas: a clinicopathologic study of 14 cases including MIB-1 and p53 immunoreactivity.
    Prayson RA
    Mod Pathol; 1997 Apr; 10(4):304-10. PubMed ID: 9110291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subependymal giant cell astrocytoma: a clinicopathologic study with HMB45 and MIB-1 immunohistochemical analysis.
    Gyure KA; Prayson RA
    Mod Pathol; 1997 Apr; 10(4):313-7. PubMed ID: 9110292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological features, MIB-1 labeling index and apoptotic index in recurrent astrocytic tumors.
    Ralte AM; Sharma MC; Karak AK; Mehta VS; Sarkar C
    Pathol Oncol Res; 2001; 7(4):267-78. PubMed ID: 11882906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic pleomorphic xanthoastrocytoma.
    Prayson RA; Morris HH
    Arch Pathol Lab Med; 1998 Dec; 122(12):1082-6. PubMed ID: 9870856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular proliferation in pilocytic and diffuse astrocytomas.
    Giannini C; Scheithauer BW; Burger PC; Christensen MR; Wollan PC; Sebo TJ; Forsyth PA; Hayostek CJ
    J Neuropathol Exp Neurol; 1999 Jan; 58(1):46-53. PubMed ID: 10068313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subependymomas: clinicopathologic study of 14 tumors, including comparative MIB-1 immunohistochemical analysis with other ependymal neoplasms.
    Prayson RA; Suh JH
    Arch Pathol Lab Med; 1999 Apr; 123(4):306-9. PubMed ID: 10320142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the MIB-1 labeling index as a predictor of tumor progression in pilocytic astrocytomas in children and adolescents.
    Bowers DC; Gargan L; Kapur P; Reisch JS; Mulne AF; Shapiro KN; Elterman RD; Winick NJ; Margraf LR
    J Clin Oncol; 2003 Aug; 21(15):2968-73. PubMed ID: 12885817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
    Abramovich CM; Prayson RA
    Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of proliferation index on outcome in childhood malignant gliomas: results in a multi-institutional cohort.
    Pollack IF; Hamilton RL; Burnham J; Holmes EJ; Finkelstein SD; Sposto R; Yates AJ; Boyett JM; Finlay JL
    Neurosurgery; 2002 Jun; 50(6):1238-44; discussion 1244-5. PubMed ID: 12015841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIB-1 and p53 immunocytochemistry for differentiating pilocytic astrocytomas and astrocytomas from anaplastic astrocytomas and glioblastomas in children and young adults.
    Matsumoto T; Fujii T; Yabe M; Oka K; Hoshi T; Sato K
    Histopathology; 1998 Nov; 33(5):446-52. PubMed ID: 9839169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 in astrocytic tumours: an immunohistochemical study.
    Chakrabarty A; Bridges LR; Gray S
    Neuropathol Appl Neurobiol; 1996 Aug; 22(4):311-6. PubMed ID: 8875465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.
    Czech T; Slavc I; Aichholzer M; Haberler C; Dietrich W; Dieckmann K; Koos W; Budka H
    J Neurooncol; 1999 Apr; 42(2):143-50. PubMed ID: 10421072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.
    Roessler K; Bertalanffy A; Jezan H; Ba-Ssalamah A; Slavc I; Czech T; Budka H
    J Neurooncol; 2002 Jun; 58(2):141-6. PubMed ID: 12164686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cyclin A and MIB-1 expression in astrocytic tumors using image-based cell analysis system.
    Ren Y; Munyer P; Kepes JJ; Cansler M; Collins J; Gayed B; Tawfik O
    Appl Immunohistochem Mol Morphol; 2001 Mar; 9(1):14-8. PubMed ID: 11277408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.